Important Dates
Abstract Submission Deadline: June 3, 2024
Abstract Status Notification Date: July 8, 2024
Withdrawal Deadline: August 1, 2024
Submission
Abstracts may only be submitted through the online abstract submission platform, which will open soon. Only those abstracts that have been reviewed and selected by the Scientific Planning Committee may be presented. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The organizers do not proofread or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted. For technical questions or if you have policy related questions, please contact the abstract submission help desk at abstracts@cancerimmunotherapyconference.org.
From the accepted posters, a small number of highly rated abstract authors will also be invited to deliver short oral proffered presentations of their work during the general sessions. All abstracts will be considered. If selected, instructions will be sent to the Submitting Author with the date, time, and format for the presentation.
Abstract Guidelines coming soon.
Register for the conference.
Notification of Abstract Status
Submitting Author will be notified of acceptance or rejection by email to the address provided by the abstract submitter at the time of submission.
Presentation and Publication
The titles and presenting authors of all regular abstracts scheduled for presentation at CICON24 will be available online prior to the conference. With the exception of abstracts selected for a conference press program (if applicable), all conference abstracts will not be available until several days prior to the start of the conference.
Poster board dimensions will be provided in email correspondence to the Submitting Author. The organizers will provide poster numbers and pushpins.
Conference Registration
Presenting Authors must register for the conference prior to the submission of an abstract and attend the session in which the abstract is scheduled.
Request for Withdrawal
Once an abstract has been submitted, it may be withdrawn only by written request from the Submitting Author. The request may be sent by email to abstracts@cancerimmunotherapyconference.org and must be received by August 1, 2024.
If due to unforeseen circumstances the designated Presenting Author is unavailable to attend the session to present the abstract, the Submitting Author must contact abstracts@cancerimmunotherapyconference.org to designate a co-author to serve as the Presenting Author. If no authors are available to present the abstract, the Submitting Author must withdraw the abstract immediately by emailing abstracts@cancerimmunotherapyconference.org.
Abstract Categories
Neoadjuvant and Platform Trials
Multiomic Data Analysis: Searching for Mechanistic Insights
Tertiary Lymphoid Aggregates as Regulators of Anti-Cancer Immunity
Immune Health and Inflammation as Precursors to Cancer
The Role of Myeloid Cells in the Anti-tumor Response
New Tools, Technologies, and Approaches in Cancer Immunotherapy
Metabolism: Metabolomic Pathways in the Clinic
Microbiome --> Diet and Microbiome
Moving Toward Personalized Therapies: Cellular & Vaccines
Clinical Trials
Other